Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Revenue

In the year 2024, Marker Therapeutics had annual revenue of $6.59M with 99.06% growth. Marker Therapeutics had revenue of $2.25M in the quarter ending December 31, 2024, with 113.13% growth.

• Revenue (ttm): $6.59M
• Revenue Growth: +99.06%
• P/S Ratio: 1.59
• Revenue / Employee: $1,318,216
• Employees: 5
• Market Cap: 12.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.59M	3.28M	99.06%
Dec 31, 2023	3.31M	-202.41K	-5.76%
Dec 31, 2022	3.51M	2.27M	182.96%
Dec 31, 2021	1.24M	774.93K	166.01%
Dec 31, 2020	466.79K	253.59K	118.95%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.